KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization-Reference-Cited by-同舟云学术

KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization

Published:2009-04-13 Issue:1 Volume:76 Page:153-162
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Symons Kent T.,Massari Mark E.,Nguyen Phan M.,Lee Tom T.,Roppe Jeffrey,Bonnefous Céline,Payne Joseph E.,Smith Nicholas D.,Noble Stewart A.,Sablad Marciano,Rozenkrants Natasha,Zhang Yan,Rao Tadimeti S.,Shiau Andrew K.,Hassig Christian A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference32 articles.

1. Systemic Antifungal Agents

2. Mechanistic Studies with Potent and Selective Inducible Nitric-oxide Synthase Dimerization Inhibitors

3. Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor

4. Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors

5. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis;European Journal of Medicinal Chemistry;2021-03

2. Induction of PD-L1 by Nitric Oxide via JNK Activation in A172 Glioblastoma Cells;Biological and Pharmaceutical Bulletin;2020-06-01

3. Inducible nitric oxide synthase: Regulation, structure, and inhibition;Medicinal Research Reviews;2019-06-13

4. Novel Pyrazolo[4,3-d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model;Journal of Medicinal Chemistry;2019-03-29

5. Protein–protein interactions as drug targets;Future Medicinal Chemistry;2015-10